New-Born Screening Market Research Report - Global Forecast till 2027

Global New-Born Screening Market: Information by Product (Reagents and Assay Kits and Instruments), by Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays and Pulse Oximetry), by Test Type (Dry Blood Spot Test, Hearing Screening Test and Critical Congenital Heart Disease (CCHD) Test), by End User (Hospitals, Maternity and Specialty Clinics and Diagnostic Centers) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/5099-CR | October 2019 | Region: Global | 141 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


The new-born screening market is evolving at a rapid pace over the years and is expected to reach a market valuation of USD 1545.98 million by 2025. The CAGR of the global new-born screening market is presumed to achieve 13.33 percent during the forecast period of 2018-2025.


The new-born screening is a process of inspecting newborn babies using devices to find out the chances of having diseases that were invisible at the birth time. The increasing cases of new-born diseases have propelled the new-born screening market growth in recent times. Government support for new-born screening processes has pushed the new-born screening market growth to the optimum level. The rising population of neo-natal and various types of new-born screening programs has ensured the escalation of new-born screening market potential during the forecast years.


The incorporation of technological advancements in screening procedures has surged the growth of the new-born screening market size.  There is a rapid increase in the expenditure spent on the healthcare sector, and industry is an important factor that drives the new-born screening market growth to maximum limits. Numerous benefits of the newborn screening test market impact the market growth positively. Governments of several regions are supporting and contributing towards the expansion of the new-born screening market size. These governments are taking steps to raise awareness and different initiatives that will contribute towards the growth of the new-born screening market.


Several non-government and government organizations are facilitating care options for both baby and the mother. The American Society of Hematology launched a campaign in June 2018 to combat sickle cell disease in Africa and requested governments of that region for investing in the processes of new-born screening. The government is also encouraging manufacturers to develop other variety of screening tests by loosening their regulations in product manufacturing and marketing.


The US Food and Drug Administration or FDA in 2017 allowed the seeker system marketing for scanning four uncommon lysosomal storage disorders (LSDs) prevalent in newborn babies. The systems are designed specifically for detecting diseases like Gaucher, Fabry, Pompe, and Mucopolysaccharidosis Type I or MPS I. These initiatives by several governments and non-government organizations will thrust the potential new-born screening market industry in the near future.


The report provides a detailed analysis of the newborn screening market and the impact of the COVID19 pandemic on the new-born screening market growth. It covers the market dynamics and reflects the insights of new-born screening market growth opportunities as well as threats. It includes the details of revenue estimation in the forecast period and the key players of the market that will influence the new-born screening market share in the upcoming times. The report represents different segments of the market and geographical areas that can impact the potential of the new-born screening market.


COVID19 Analysis


The impact of the coronavirus outbreak has shattered the global economy and pulled it downwards. A major crisis happened in the health sector as well as the financial sector. The closure of working areas and businesses has ruined the market stability worldwide. The economic growth rate has declined to lower levels, and financial struggle is seen everywhere globally. The lockdown restrictions completely shut down the industrial operations, which impacted the production of screening systems. However, the new-born screening market was still sustaining steady market growth. The reason behind the growth is the rapidly increasing cases of diseases in newborn babies.


During the pandemic, a significant rise in diseases demanded a heavy amount of screening systems which propelled the new-born screening market towards growth. The new-born screening market industry is constantly working on producing new and advanced screening systems that will ensure better quality detection. The rising demand for newborn screening systems will expand the new-born screening market size in the upcoming years.


Market Dynamics



  • Major drivers of the market


The global new-born screening market is reaching optimum heights and is rapidly progressing in increasing the new-born screening market size. The population of newborn babies is increasing day by day, which requires immense growth of the new-born screening market industry. Technological advancements in developing the new-born screening systems will boost the new-born screening market growth. Governments of several countries are supporting different newborn screening programs and taking numerous initiatives along with raising awareness among people about new-born screening and the advantages attached to it.


Various non-government and government organizations are providing better care options for the health of both baby and mother. The government is also relaxing regulations on the manufacturing and marketing of screening systems that will encourage manufacturers to produce better varieties of newborn screening systems. Campaigns for spreading awareness about diseases will evolve the potential of the new-born screening market.



  • Significant Opportunities for the market


The new-born screening market size will exhilarate quickly in the forecast years, and the rising demand for newborn screening systems will boost the market growth. Several technological advancements in the newborn screening system will behave as a market booster for the new-born screening market growth. The increasing population of the new-born child will contribute immensely towards the expansion of the new-born screening market share. Different countries' governments are also spreading awareness about the screening processes of newborn children and taking initiatives to support the new-born screening market. All these opportunities will force the new-born screening market growth to a greater extent in the forecast period.



  • Market Restraints


The coronavirus outbreak has impacted the new-born screening test market and became a major constraint in the market growth. The lockdown measures forced the manufacturing units and operations of industries to shut down. The demand to supply gap was getting broader, and the supply chain of industries was disrupted. But the pandemic had very less impact on the newborn screening test market. The increase in the newborn population demanded the rise of the new-born screening market industry. The new-born screening market potential will soon gain its momentum and excel in the near future.



  • Market growth Challenges


The new-born screening market size is definitely expanding at a faster rate, but the market possesses certain challenges too. The scarcity of proper healthcare facilities and infrastructure is a bigger challenge in the path of new-born screening market growth. Newborn screening tests sometimes lack accuracy, which creates unreliability on the product. There are very few proficient professionals available who can handle the screening test properly, which creates a hindrance in the growth path of the new-born screening market.


Value Chain Analysis


The value obtained by the newborn screening test market will rise to greater limits in the upcoming years. The new-born screening market share will exhilarate rapidly in the global economy. By the end of 2025, the new-born screening market industry will reach optimum heights and contribute heavily to the worldwide economy.


Segment Overview


The global new-born screeningmarket is fragmented into different segments on the basis of technology, product, test type, and end-user. The newborn screening test market segmentation on the basis of technology includes DNA assays, tandem mass spectrometry, pulse oximetry, electrophoresis, hearing screening technology, immunoassays, and enzymatic assays. Pulse oximetry will grow rapidly in the newborn screening test market, and tandem mass spectrometry is predicted to grow during the forecast period. The new-born screening market segmentation on the basis of the product involves reagents, instruments, and assay kits. The segment of the instrument is presumed to contribute more to the new-born screening market in the forecast period as awareness about screening tests is increasing.


The new-born screening market segmentation on the basis of type tests comprises of different tests like critical congenital heart disease or CCHD test, dry blood spot test, hearing screening test, and urine test. The dry blood spot test is expected to hold a new-born screening market share in the upcoming years as the diseases in newborn babies are increasing. The new-born screening market segmentation on the basis of end-user includes different sectors such as diagnostics centers, maternity and specialty clinics, hospitals, and many more. Hospitals will evolve more during the forecast period as government support helps the new-born screening market grow.


Regional Analysis


The global new-born screening market is studied in different geographies such as North America, South America, Asia Pacific, Europe, Middle East, and Africa. The Americas have the majority control on the new-born screening market share as congenital disorder is prevalent in newborn babies. The rising population of newborn and government support boosts the market growth in this region boost the new-born screening market growth immensely. Following newborn screening programs is compulsory everywhere in North America and in the US, both federal and state governments make policies for supporting the new-born screening market.


Competitive Landscape of the market


The major players of new-born screening market are:



  • Waters (US)

  • SCIEX (US)

  • Natus Medical Incorporated (US)

  • PerkinElmer Inc. (US)

  • Masimo Corporation (US)

  • Bio-Rad Laboratories, Inc. (US)

  • Agilent Technologies Inc. (US)

  • GENERAL ELECTRIC (Boston)

  • Medtronic PLC (Ireland)

  • Trivitron Healthcare (India)

  • Thermo Fisher Scientific Inc. (US)

  • ZenTech SA (Belgium)



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 1545.98 Million
  CAGR   13.33% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Technology, Test Type and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   SCIEX (US), PerkinElmer Inc. (US), WATERS (US), Natus Medical Incorporated (US), Masimo Corporation (US), Agilent Technologies Inc. (US), Bio-Rad Laboratories, Inc. (US), Medtronic (Ireland), GENERAL ELECTRIC (Boston), Trivitron Healthcare (India), and ZenTech SA (Belgium)
  Key Market Opportunities

  • Rising demand for newborn screening systems
  • Technological advancements in the newborn screening system
  • Increasing population of the new-born child
  •   Key Market Drivers

  • Population of newborn babies is increasing day by day
  • Various non-government and government organizations are providing better care options for the health of both baby and mother


  • Frequently Asked Questions (FAQ) :


    The global new-born screening market is projected to reach a valuation of USD 1545.98 MN by 2025.

    The global new-born screening market is projected to grow at approximately 13.33% CAGR during forecast period (2020-2027).

    North America holds the largest share in the global new-born screening market, followed by Europe and the Asia Pacific, respectively.

    PerkinElmer Inc. (US), SCIEX (US), Waters (US), Masimo Corporation (US), Natus Medical Incorporated (US), Agilent Technologies Inc. (US), Medtronic PLC (Ireland), Bio-Rad Laboratories, Inc. (US), GENERAL ELECTRIC (Boston), ZenTech SA (Belgium), Trivitron Healthcare (India), and Thermo Fisher Scientific Inc. (US), are some of the major players operating in the new-born screening market.

    1 Report Prologue

    2 Executive Summary

    3 Market Introduction

    3.1 Definition 20

    3.2 Scope of the Study 20

    3.3 Assumptions & Limitations 20

    3.3.1 Assumptions 20

    3.3.2 Limitations 20

    3.4 Market Structure 21

    4 Research Methodology

    4.1 Research Process 23

    4.2 Primary Research 24

    4.3 Secondary Research 25

    4.4 Market Size Estimation 26

    4.5 Forecast Model 26

    5 Market Dynamics

    5.1 Introduction 28

    5.2 Drivers 29

    5.2.1 Rising Prevalence of Diseases in New-Born Children 29

    5.2.2 Government Support and New-Born Screening Programs 29

    5.2.3 Increasing Neonatal Population 29

    5.2.4 Technological Advancements 30

    5.3 Restraints 30

    5.3.1 Unreliability of Few New-Born Screening Tests 30

    5.3.2 Lack of Proper Healthcare Infrastructure and Trained Professionals 30

    5.4 Opportunities 31

    5.4.1 Screening of Genetic Diseases 31

    5.5 Challenges 31

    5.5.1 Heavy Cost of Automation Technology 31

    6 Market Factor Analysis

    6.1 Porter’s Five Forces Model 33

    6.1.1 Bargaining Power of Suppliers 33

    6.1.2 Bargaining Power of Buyers 33

    6.1.3 Threat of New Entrants 34

    6.1.4 Threat of Substitutes 34

    6.1.5 Intense Rivalry 34

    6.2 Supply Chain Analysis 35

    6.2.1 R&D and Designing 35

    6.2.2 Manufacturing 35

    6.2.3 Distribution & Sales 35

    6.2.4 Post-Sales Monitoring 35

    7 New-Born Screening Market, By Product

    7.1 Introduction 37

    7.2 Reagents and Assay Kits 38

    7.3 Instruments 39

    8 New-Born Screening Market, By Technology

    8.1 Introduction 42

    8.2 Tandem Mass Spectrometry 43

    8.3 Immunoassays and Enzymatic Assays 44

    8.4 Hearing Screening Technology 45

    8.5 DNA Assays 46

    8.6 Pulse Oximetry 47

    9 New-Born Screening Market, By Test Type

    9.1 Introduction 49

    9.2 Dry Blood Spot Test 50

    9.3 Hearing Screening Test 51

    9.4 Critical Congenital Heart Disease (CCHD) Test 52

    10 New-Born Screening Market, By End-User

    10.1 Introduction 54

    10.2 Hospitals 55

    10.3 Maternity and Specialty Clinics 56

    10.4 Diagnostic Centers 56

    11 Global New-Born screening Market, By Region

    11.1 Introduction 58

    11.2 Americas 59

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.2.1 North America 62

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.2.1.1 U.S. 64

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.2.1.2 Canada 66

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.2.2 South America 68

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3 Europe 70

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1 Western Europe 72

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1.1 Germany 74

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1.2 France 76

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1.3 UK 78

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1.4 Italy 80

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1.5 Spain 82

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.1.6 Rest of Western Europe 84

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.3.2 Eastern Europe 86

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4 Asia-Pacific 88

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4.1 Japan 91

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4.2 China 93

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4.3 India 95

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4.4 Australia 97

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4.5 Republic of Korea 99

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.4.6 Rest of Asia-Pacific 101

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.5 Middle East and Africa 103

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.5.1 Middle East 105

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    11.5.2 Africa 107

    New-Born Screening Market, By Product

    New-Born Screening Market, By Technology

    New-Born Screening Market, By Test Type

    New-Born Screening Market, By End-User

    12 Competitive Landscape

    12.1 Company Market Share Analysis 110

    12.1.1 Introduction 110

    13 Company Profiles

    13.1 SCIEX 113

    13.1.1 Company Overview 113

    13.1.2 Financial Overview 113

    13.1.3 Products/Services Offered 114

    13.1.4 SWOT Analysis 114

    13.1.5 Key Developments 114

    13.1.6 Key Strategy 114


    13.2 PerkinElmer Inc. 115

    13.2.1 Company Overview 115

    13.2.2 Financial Overview 115

    13.2.3 Products/Services Offered 116

    13.2.4 SWOT Analysis 116

    13.2.5 Key Developments 116

    13.2.6 Key strategy 117

    13.3 WATERS 118

    13.3.1 Company Overview 118

    13.3.2 Financial Overview 118

    13.3.3 Products/Services Offered 119

    13.3.4 SWOT Analysis 119

    13.3.5 Key Developments 119

    13.3.6 Key strategy 119

    13.4 Natus Medical Incorporated 120

    13.4.1 Company Overview 120

    13.4.2 Financial Overview 120

    13.4.3 Products/Services Offered 121

    13.4.4 SWOT Analysis 121

    13.4.5 Key Developments 121

    13.4.6 Key Strategy 121

    13.5 Masimo Corporation 122

    13.5.1 Company Overview 122

    13.5.2 Financial Overview 122

    13.5.3 Products/Services Offered 123

    13.5.4 SWOT Analysis 123

    13.5.5 Key Developments 123

    13.5.6 Key Strategy 123

    13.6 Agilent Technologies Inc. 124

    13.6.1 Company Overview 124

    13.6.2 Financial Overview 124

    13.6.3 Products/Services Offered 125

    13.6.4 SWOT Analysis 125

    13.6.5 Key Development 125

    13.6.6 Key Strategy 125

    13.7 Bio-Rad Laboratories, Inc. 126

    13.7.1 Company Overview 126

    13.7.2 Financial Overview 126

    13.7.3 Products/Services Offered 127

    13.7.4 SWOT Analysis 127

    13.7.5 Key Development 127

    13.7.6 Key Strategy 127

    13.8 Medtronic 128

    13.8.1 Company Overview 128

    13.8.2 Financial Overview 128

    13.8.3 Products/Services Offered 129

    13.8.4 SWOT Analysis 129

    13.8.5 Key Development 129

    13.8.6 Key Strategy 129

    13.9 GENERAL ELECTRIC COMPANY 130

    13.9.1 Company Overview 130

    13.9.2 Financial Overview 130

    13.9.3 Products/Services Offered 131

    13.9.4 SWOT Analysis 131

    13.9.5 Key Development 131

    13.9.6 Key Strategy 131

    13.10 Trivitron Healthcare 132

    13.10.1 Financial Overview 132

    13.10.2 Products/Services Offered 132

    13.10.3 SWOT Analysis 133

    13.10.4 Key Development 133

    13.10.5 Key Strategy 133

    13.11 ZenTech SA 134

    13.11.1 Company Overview 134

    13.11.2 Financial Overview 134

    13.11.3 Products/Services Offered 134

    13.11.4 SWOT Analysis 135

    13.11.5 Key Development 135

    13.11.6 Key Strategy 135


    13.12 Thermo Fisher Scientific Inc. 136

    13.12.1 Company Overview 136

    13.12.2 Financial Overview 136

    13.12.3 Products/Services Offered 137

    13.12.4 SWOT Analysis 137

    13.12.5 Key Development 137

    13.12.6 Key Strategy 137

    14 Appendix

    14.1 Discussion Blue Print 139

    15 List of Tables

    TABLE 1 MARKET SYNOPSIS 18

    TABLE 2 PRIMARY INTERVIEWS 23

    TABLE 3 GLOBAL NEW-BORN SCREENING MARKET BY PRODUCT, 2020-2027 (USD MILLION) 37

    TABLE 4 GLOBAL NEW-BORN SCREENING MARKET FOR REAGENTS AND ASSAY BY REGION, 2020-2027 (USD MILLION) 38

    TABLE 5 GLOBAL NEW-BORN SCREENING MARKET FOR INSTRUMENTS BY REGION, 2020-2027 (USD MILLION) 39

    TABLE 6 GLOBAL NEW-BORN SCREENING MARKET FOR INSTRUMENTS BY TYPE, 2020-2027 (USD MILLION) 40

    TABLE 7 GLOBAL NEW-BORN SCREENING MARKET BY TECHNOLOGY, 2020-2027 (USD MILLION) 43

    TABLE 8 GLOBAL NEW-BORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY BY REGION, 2020-2027 (USD MILLION) 43

    TABLE 9 GLOBAL NEW-BORN SCREENING MARKET FOR IMMUNOASSAY AND ENZYMATIC ASSAYS BY REGION,

    2020-2027 (USD MILLION) 44

    TABLE 10 GLOBAL NEW-BORN SCREENING MARKET FOR HEARING SCREENING TECHNOLOGY BY REGION, 2020-2027 (USD MILLION) 45

    TABLE 11 GLOBAL NEW-BORN SCREENING MARKET FOR DNA ASSAY BY REGION, 2020-2027 (USD MILLION) 46

    TABLE 12 GLOBAL NEW-BORN SCREENING MARKET FOR PULSE OXIMETRY BY REGION, 2020-2027 (USD MILLION) 47

    TABLE 13 GLOBAL NEW-BORN SCREENING MARKET BY TEST TYPE, 2020-2027 (USD MILLION) 50

    TABLE 14 GLOBAL NEW-BORN SCREENING MARKET FOR DRY BLOOD SPOT BY REGION, 2020-2027 (USD MILLION) 50

    TABLE 15 GLOBAL NEW-BORN SCREENING MARKET FOR HEARING SCREENING TEST BY REGION, 2020-2027 (USD MILLION) 51

    TABLE 16 GLOBAL NEW-BORN SCREENING MARKET FOR CRITICAL CONGENITAL HEART DISEASE TEST BY REGION,

    2020-2027 (USD MILLION) 52

    TABLE 17 GLOBAL NEW-BORN SCREENING MARKET BY END-USER, 2020-2027 (USD MILLION) 55

    TABLE 18 GLOBAL NEW-BORN SCREENING MARKET FOR HOSPITALS BY REGION, 2020-2027 (USD MILLION) 55

    TABLE 19 GLOBAL NEW-BORN SCREENING MARKET FOR MATERNITY AND SPECIALTY CLINICS BY REGION, 2020-2027 (USD MILLION) 56

    TABLE 20 GLOBAL NEW-BORN SCREENING MARKET FOR DIAGNOSTIC CENTERS BY REGION, 2020-2027 (USD MILLION) 56

    TABLE 21 GLOBAL NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 59

    TABLE 22 AMERICAS: NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 59

    TABLE 23 AMERICAS: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 60

    TABLE 24 AMERICAS: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 60

    TABLE 25 AMERICAS: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 60

    TABLE 26 AMERICAS: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 61

    TABLE 27 AMERICAS: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 61

    TABLE 28 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 62

    TABLE 29 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 62

    TABLE 30 NORTH AMERICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 62

    TABLE 31 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 63

    TABLE 32 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 63

    TABLE 33 NORTH AMERICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 63

    TABLE 34 U.S.: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 64

    TABLE 35 U.S.: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 64

    TABLE 36 U.S.: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 64

    TABLE 37 U.S.: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 65

    TABLE 38 U.S.: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 65

    TABLE 39 CANADA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 66

    TABLE 40 CANADA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 66

    TABLE 41 CANADA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 66

    TABLE 42 CANADA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 67

    TABLE 43 CANADA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 67

    TABLE 44 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 68

    TABLE 45 SOUTH AMERICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 68

    TABLE 46 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 68

    TABLE 47 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 69

    TABLE 48 SOUTH AMERICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 69

    TABLE 49 EUROPE: NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 70

    TABLE 50 EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 70

    TABLE 51 EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 71

    TABLE 52 EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 71

    TABLE 53 EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 71

    TABLE 54 EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 72

    TABLE 55 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 72

    TABLE 56 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION 72

    TABLE 57 WESTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 73

    TABLE 58 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 73

    TABLE 59 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 73

    TABLE 60 WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 74

    TABLE 61 GERMANY: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 74

    TABLE 62 GERMANY: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 74

    TABLE 63 GERMANY: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 75

    TABLE 64 GERMANY: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 75

    TABLE 65 GERMANY: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 75

    TABLE 66 FRANCE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 76

    TABLE 67 FRANCE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 76

    TABLE 68 FRANCE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 76

    TABLE 69 FRANCE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 77

    TABLE 70 FRANCE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 77

    TABLE 71 UK: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 78

    TABLE 72 UK: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 78

    TABLE 73 UK: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 78

    TABLE 74 UK: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 79

    TABLE 75 UK: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 79

    TABLE 76 ITALY: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 80

    TABLE 77 ITALY: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 80

    TABLE 78 ITALY: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 80

    TABLE 79 ITALY: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 81

    TABLE 80 ITALY: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 81

    TABLE 81 SPAIN: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 82

    TABLE 82 SPAIN: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 82

    TABLE 83 SPAIN: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 82

    TABLE 84 SPAIN: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 83

    TABLE 85 SPAIN: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 83

    TABLE 86 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 84

    TABLE 87 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 84

    TABLE 88 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 84

    TABLE 89 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 85

    TABLE 90 REST OF WESTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 85

    TABLE 91 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 86

    TABLE 92 EASTERN EUROPE: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 86

    TABLE 93 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 86

    TABLE 94 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 87

    TABLE 95 EASTERN EUROPE: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 87

    TABLE 96 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 88

    TABLE 97 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 89

    TABLE 98 ASIA-PACIFIC: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 89

    TABLE 99 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 89

    TABLE 100 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 90

    TABLE 101 ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 90

    TABLE 102 JAPAN: NEW-BORN SCREENING MARKET, BY PRODUCTS, 2020-2027 (USD MILLION) 91

    TABLE 103 JAPAN: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 91

    TABLE 104 JAPAN: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 91

    TABLE 105 JAPAN: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 92

    TABLE 106 JAPAN: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 92

    TABLE 107 CHINA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 93

    TABLE 108 CHINA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 93

    TABLE 109 CHINA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 93

    TABLE 110 CHINA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 94

    TABLE 111 CHINA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 94

    TABLE 112 INDIA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 95

    TABLE 113 INDIA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 95

    TABLE 114 INDIA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 95

    TABLE 115 INDIA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 96

    TABLE 116 INDIA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 96

    TABLE 117 AUSTRALIA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 97

    TABLE 118 AUSTRALIA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 97

    TABLE 119 AUSTRALIA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 97

    TABLE 120 AUSTRALIA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 98

    TABLE 121 AUSTRALIA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 98

    TABLE 122 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 99

    TABLE 123 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 99

    TABLE 124 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 99

    TABLE 125 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 100

    TABLE 126 REPUBLIC OF KOREA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 100

    TABLE 127 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 101

    TABLE 128 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 101

    TABLE 129 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 101

    TABLE 130 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 102

    TABLE 131 REST OF ASIA-PACIFIC: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 102

    TABLE 132 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY REGION, 2020-2027 (USD MILLION) 103

    TABLE 133 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 103

    TABLE 134 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 104

    TABLE 135 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 104

    TABLE 136 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 104

    TABLE 137 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 105

    TABLE 138 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 105

    TABLE 139 MIDDLE EAST: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 105

    TABLE 140 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 106

    TABLE 141 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 106

    TABLE 142 MIDDLE EAST: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 106

    TABLE 143 AFRICA: NEW-BORN SCREENING MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 107

    TABLE 144 AFRICA: NEW-BORN SCREENING MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION) 107

    TABLE 145 AFRICA: NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 107

    TABLE 146 AFRICA: NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020-2027 (USD MILLION) 108

    TABLE 147 AFRICA: NEW-BORN SCREENING MARKET, BY END-USER, 2020-2027 (USD MILLION) 108

    16 List of Figures

    FIGURE 1 GLOBAL NEW-BORN SCREENING MARKET: MARKET STRUCTURE 21

    FIGURE 2 RESEARCH PROCESS 23

    FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

    FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NEW-BORN SCREENING MARKET 28

    FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL NEW-BORN SCREENING MARKET 33

    FIGURE 6 SUPPLY CHAIN: GLOBAL NEW-BORN SCREENING MARKET 35

    FIGURE 7 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY PRODUCT, 2020 (%) 37

    FIGURE 8 GLOBAL NEW-BORN SCREENING MARKET, BY PRODUCT, 2020 & 2027 37

    FIGURE 9 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY TECHNOLOGY, 2020 (%) 42

    FIGURE 10 GLOBAL NEW-BORN SCREENING MARKET, BY TECHNOLOGY, 2020 & 2027 42

    FIGURE 11 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY TEST TYPE, 2020 (%) 49

    FIGURE 12 GLOBAL NEW-BORN SCREENING MARKET, BY TEST TYPE, 2020 & 2027 49

    FIGURE 13 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY END-USER, 2020 (%) 54

    FIGURE 14 GLOBAL NEW-BORN SCREENING MARKET, BY END-USER, 2020 & 2027 54

    FIGURE 15 GLOBAL NEW-BORN SCREENING MARKET, BY REGION, 2020 & 2027 (USD MILLION) 58

    FIGURE 16 GLOBAL NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 58

    FIGURE 17 AMERICAS: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 59

    FIGURE 18 EUROPE: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 70

    FIGURE 19 ASIA-PACIFIC: NEW-BORN SCREENING MARKET SHARE, BY COUNTRY, 2020 (%) 88

    FIGURE 20 MIDDLE EAST AND AFRICA: NEW-BORN SCREENING MARKET SHARE, BY REGION, 2020 (%) 103

    FIGURE 21 GLOBAL NEWBORN SCREENING MARKET, MARKET SHARE ANALYSIS 2020 (%) 110